Alaunos Therapeutics, Inc.

TCRT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$5-$35-$38-$79
Dep. & Amort.$0$2$3$3
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$4$11
Change in WC-$1-$6$1$3
Other Non-Cash$0$6$1$1
Operating Cash Flow-$5-$30-$29-$61
Investing Activities
PP&E Inv.$0-$0-$0-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$2$0$0
Investing Cash Flow$0$1-$0-$3
Financing Activities
Debt Repay.$0-$18-$8$25
Stock Issued$0$0$15$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0$1
Financing Cash Flow$0-$18$6$26
Forex Effect$0$0$0$0
Net Chg. in Cash-$5-$47-$23-$39
Supplemental Information
Beg. Cash$6$53$76$115
End Cash$1$6$53$76
Free Cash Flow-$5-$30-$29-$65
Alaunos Therapeutics, Inc. (TCRT) Financial Statements & Key Stats | AlphaPilot